» Articles » PMID: 33937336

MicroRNA-653-5p Promotes Gastric Cancer Proliferation and Metastasis by Targeting the SOCS6-STAT3 Pathway

Overview
Specialty Biology
Date 2021 May 3
PMID 33937336
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) are emerging as significant regulators of the tumorigenesis of gastric cancer (GC), and may be effective biomarkers for diagnosis, prognosis, and therapeutic targeting for GC. In this study, miR-653-5p was found to be significantly upregulated in GC tissues, serum, and cell lines and was strongly associated with poor prognosis in patients with GC. Furthermore, miR-653-5p promoted GC cell proliferation and metastasis and . Suppressor of cytokine signaling 6 (SOCS6) was directly targeted by miR-653-5p, and SOCS6 attenuated miR-653-5p-mediated GC cell growth, migration, and invasion. In addition, SOCS6-mediated inactivation of the Janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3) signaling pathway was also reversed by the administration of miR-653-5p. The findings from this study support a novel regulatory axis between miR-653-5p, SOCS6, and JAK2/STAT3 that may be a target for diagnosis and therapeutic intervention for GC.

Citing Articles

Combinatorial phenethyl isothiocyanate and withaferin A targets multiple epigenetics pathways to inhibit MCF-7 and MDA-MB-231 human breast cancer cells.

Rahman M, Tollefsbol T Cancer Cell Int. 2024; 24(1):422.

PMID: 39707321 PMC: 11662855. DOI: 10.1186/s12935-024-03619-4.


The Neglected Suppressor of Cytokine Signalling (SOCS): SOCS4-7.

Herrera-Uribe J, Convery O, ALmohammadi D, Weinberg F, Stevenson N Inflammation. 2024; .

PMID: 39460806 DOI: 10.1007/s10753-024-02163-7.


Genes Related to Frontonasal Malformations Are Regulated by miR-338-5p, miR-653-5p, and miR-374-5p in O9-1 Cells.

Iwaya C, Yu S, Iwata J J Dev Biol. 2024; 12(3).

PMID: 39051201 PMC: 11270360. DOI: 10.3390/jdb12030019.


Bibliometric and visualized analysis of global research on microRNAs in gastric cancer: from 2013 to 2023.

Wang X, Wang C, Han W, Ma C, Sun J, Wang T Front Oncol. 2024; 14:1374743.

PMID: 38800413 PMC: 11116657. DOI: 10.3389/fonc.2024.1374743.


TP53 mitigates cisplatin resistance in non-small cell lung cancer by mediating the effects of resistant cell-derived exosome mir-424-5p.

Deng Y, Ding H, Zhang Y, Feng X, Ye Q, Tian R Heliyon. 2024; 10(5):e26853.

PMID: 38439876 PMC: 10909722. DOI: 10.1016/j.heliyon.2024.e26853.


References
1.
Shen R, Wang Y, Wang C, Yin M, Liu H, Chen J . MiRNA-155 mediates TAM resistance by modulating SOCS6-STAT3 signalling pathway in breast cancer. Am J Transl Res. 2015; 7(10):2115-26. PMC: 4656789. View

2.
Shiotani A, Murao T, Kimura Y, Matsumoto H, Kamada T, Kusunoki H . Identification of serum miRNAs as novel non-invasive biomarkers for detection of high risk for early gastric cancer. Br J Cancer. 2013; 109(9):2323-30. PMC: 3817334. DOI: 10.1038/bjc.2013.596. View

3.
Jiang M, Zhang W, Liu P, Yu W, Liu T, Yu J . Dysregulation of SOCS-Mediated Negative Feedback of Cytokine Signaling in Carcinogenesis and Its Significance in Cancer Treatment. Front Immunol. 2017; 8:70. PMC: 5296614. DOI: 10.3389/fimmu.2017.00070. View

4.
Wu W, Lee C, Cho C, Fan D, Wu K, Yu J . MicroRNA dysregulation in gastric cancer: a new player enters the game. Oncogene. 2010; 29(43):5761-71. DOI: 10.1038/onc.2010.352. View

5.
Lee R, Feinbaum R, Ambros V . The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993; 75(5):843-54. DOI: 10.1016/0092-8674(93)90529-y. View